Phialogics
Biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation
Total raised
€600k
€600,000
Funding rounds
1
Investors
1
distinct backers
Active since
2023-04
latest 2023-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood17
base rate 24% for Pre-Seed
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-19 | Pre-Seed | €600k | High-Tech Gründerfonds (HTGF) | View deal → |
Investors
1Related news
- Phialogics closes 600,000 € pre-seed financing roundstartupticker.ch · 2023-04
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy